NICE has been notified about this procedure and will consider it as part of its work programme.
The NICE Interventional Procedures Advisory Committee agreed to combine this procedure with Electrochemotherapy for metastases in the skin (from non-skin origin and melanoma) (IP984) and produce a single piece of guidance.
For further information please go to IP984 Electrochemotherapy for metastases in the skin (of non-skin origin and melanoma)
| Status | Discontinued |
| Decision | Selected |
| Process | IPG |
| Referral date | 01 May 2012 |
| Description | Electrochemotherapy is a treatment option for malignant melanoma. It has been developed for management of lesions that have not responded to standard treatments such as chemotherapy, radiotherapy or surgery. This procedure involves injecting a chemotherapeutic drug either directly into the skin tumours or intravenously. Short and intense electric pulses are applied to tumour cells to open up the pores with the aim of improving delivery of poor or non-permeating chemotherapy drugs and increasing treatment effectiveness. |
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 30 August 2016 | Discontinued. The NICE Interventional Procedures Advisory Committee agreed to combine this procedure with Electrochemotherapy for metastases in the skin (from non-skin origin and melanoma) (IP984) and produce a single piece of guidance. For further information please go to IP984 Electrochemotherapy for metastases in the skin (of non-skin origin and melanoma) |
For further information on how we develop interventional procedures guidance, please see our interventional procedures programme manual